Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 58

Results For "marketing"

842 News Found

Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round
News | July 20, 2022

Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round

The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product


Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy
Drug Approval | July 20, 2022

Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China


Enveda appoints Vanitha Sekar as Chief Business Officer
People | July 16, 2022

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences


Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
News | July 15, 2022

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality

Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals


Cipla Health signs agreement to acquire Endura Mass
News | July 15, 2022

Cipla Health signs agreement to acquire Endura Mass

This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.


Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
Clinical Trials | July 14, 2022

Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.


Eversana partners with Compai Pharma to expand commercialisation services across APAC
News | July 13, 2022

Eversana partners with Compai Pharma to expand commercialisation services across APAC

EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners


Vacuubrand unveils new corporate identity
News | July 06, 2022

Vacuubrand unveils new corporate identity

VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering


Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China
News | July 01, 2022

Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China

Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia


JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories
News | July 01, 2022

JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories

The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores